These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 27921110
1. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells. Kong L, Qiu J, Sun W, Yang J, Shen M, Wang L, Shi X. Biomater Sci; 2017 Jan 31; 5(2):258-266. PubMed ID: 27921110 [Abstract] [Full Text] [Related]
2. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles. Kong L, Wu Y, Alves CS, Shi X. Nanomedicine (Lond); 2016 Dec 31; 11(23):3103-3115. PubMed ID: 27809656 [Abstract] [Full Text] [Related]
11. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells. Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R. Int J Pharm; 2013 Nov 18; 456(2):408-16. PubMed ID: 24012865 [Abstract] [Full Text] [Related]
12. Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo. Zhan C, Qian J, Feng L, Zhong G, Zhu J, Lu W. J Drug Target; 2011 Aug 18; 19(7):573-81. PubMed ID: 21166603 [Abstract] [Full Text] [Related]
13. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery. Prabhakar N, Zhang J, Desai D, Casals E, Gulin-Sarfraz T, Näreoja T, Westermarck J, Rosenholm JM. Int J Nanomedicine; 2016 Aug 18; 11():6591-6608. PubMed ID: 27994460 [Abstract] [Full Text] [Related]
18. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. Tong WY, Alnakhli M, Bhardwaj R, Apostolou S, Sinha S, Fraser C, Kuchel T, Kuss B, Voelcker NH. J Nanobiotechnology; 2018 Apr 13; 16(1):38. PubMed ID: 29653579 [Abstract] [Full Text] [Related]
19. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. Luan X, Rahme K, Cong Z, Wang L, Zou Y, He Y, Yang H, Holmes JD, O'Driscoll CM, Guo J. Eur J Pharm Biopharm; 2019 Apr 13; 137():56-67. PubMed ID: 30779980 [Abstract] [Full Text] [Related]